April 8, 2021

Diamyd Medical Selects Cytiva’s FlexFactory Platform to Make Precision Medicine Type-1 Diabetes Vaccine

Diamyd Medical will install a new Cytiva FlexFactory platform in Umeå, Sweden. Once up and running, the clinical-stage biopharmaceutical company will begin manufacturing its precision-medicine vaccine. The first of its kind, the type-1 diabetes vaccine works to reprogram immune cells to prevent the destruction of pancreatic insulin-producing B-cells.

Tags: enterprise, Cytiva, vaccine, FlexFactory